MiNK Therapeutics Inc (INKT) (Q2 2026) Earnings Call Highlights: AGENT-797 Shows Early Promise ...
Yahoo Finance · Aug 13, 2026 · Mink Therapeutics Inc (INKT)
MiNK Therapeutics reports encouraging initial data from its ARDS study, narrows net loss, and expands international access programs despite a tight cash position.
Not investment advice. Headline and summary only, not a full reprint.